Wednesday, November 25, 2009, 7:52am EST - Canadian Markets open in 1 hour and 38 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Durect Corp. (DRRX)

 On Nov 24: 2.25 USD   0.00 (0.00%)  
MORE ON DRRX
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Durect Corporation (NGM:DRRX) Delayed quote dataEdit
Last Trade: 2.25 USD
Trade Time: Nov 24
Change: 0.00 (0.00%)
Prev Close: 2.25
Open: N/A
Bid: 0.25 x 1000
Ask: 2,000.00 x 100
1y Target Est: 4.13
Day's Range: N/A - N/A
52wk Range: 1.40 - 4.26
Volume: 0
Avg Vol (3m): 274,071
Market Cap: 195.18M
P/E (ttm): N/A
EPS (ttm): -0.49
Div & Yield: N/A (N/A%)
Durect Corp. (DRRX)
1d  5d  3m  6m  1y  2y  5y  max 
 Add DRRX to Portfolio   Download Data

HEADLINES
• DURECT to Present at the 21st Annual Piper Jaffray Health Care Conference
PRNewswire (Mon, Nov 23)
• DURECT CORP Financials
EDGAR Online Financials (Fri, Nov 6)
• DURECT CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Nov 2)
• DURECT Corporation Earnings Call scheduled for 4:30 pm ET today
CCBN (Thu, Oct 29)
• DURECT CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Oct 29)
• DURECT Corporation Announces Third Quarter 2009 Financial Results
PRNewswire (Thu, Oct 29)
• Q3 2009 DURECT Corporation Earnings Release - After Market Close
CCBN (Thu, Oct 29)
• DURECT Corporation Invites You to Join its Third Quarter 2009 Earnings Conference Call
PRNewswire (Mon, Oct 26)
• 5 Top Stocks at Half Price
at Motley Fool (Mon, Sep 28)
• DURECT Corporation to Participate in Upcoming Healthcare Conferences
PRNewswire (Thu, Sep 17)
More Headlines for DRRX...
ANALYST
EPS Est (next year) (Dec-09) : -0.34
EPS Est (in 2 years) (Dec-10) : -0.29
Avg Rec (current)*: 1.3
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
DURECT Corporation, a specialty pharmaceutical company, focuses on the development of pharmaceutical products for pain, central nervous system, disorders, cardiovascular disease, and other chronic diseases based on its proprietary drug formulation...

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices